Biometrics. 1988 Jun;44(2):579-85.

The B-value: a tool for monitoring data.

Source

Biostatistics Research Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Abstract

This paper considers the problem of monitoring slowly accruing data from a nonsequentially designed experiment. We describe the use of the B-value, which is a transformed Z-value, for the calculation of conditional power. In data monitoring, interim Z-values do not allow simple projections to the end of the study. Moreover, because of their popular association with P-values, Z-values are often misinterpreted. If observed trends are viewed as the realization of a Brownian motion process, the B-value and its decomposition allow simple extrapolations to the end of the study under a variety of hypotheses. Applications are presented to one- and two-sample Z-tests, the two-sample Wilcoxon rank sum test, and the log-rank test.

PMID:: 3390511; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Propranolol

LinkOut - more resources

Education

New England Research Institutes Inc.

Medical

Molecular Biology Databases

PROPRANOLOL HYDROCHLORIDE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. [Biometrics. 1998]
Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
Tan M, Xiong X, Kutner MH. Biometrics. 1998 Jun; 54(2):682-95.
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit. [Clin Trials. 2009]
Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM. Clin Trials. 2009 Dec; 6(6):565-73. Epub 2009 Nov 23.
Review A review of methods for futility stopping based on conditional power. [Stat Med. 2005]
Review A review of methods for futility stopping based on conditional power.
Lachin JM. Stat Med. 2005 Sep 30; 24(18):2747-64.
Interim analysis and sample size reassessment. [Biometrics. 2000]
Interim analysis and sample size reassessment.
Posch M, Bauer P. Biometrics. 2000 Dec; 56(4):1170-6.
Review Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses. [Control Clin Trials. 1999]
Review Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
Gu M, Lai TL. Control Clin Trials. 1999 Oct; 20(5):423-38.

See reviews... See all...

Cited by 6 PubMed Central articles

Gender rather than choice of intermediate duration opioids affects emergence after craniotomy for large intracranial tumors. [Ochsner J. 2011]
Gender rather than choice of intermediate duration opioids affects emergence after craniotomy for large intracranial tumors.
Deogaonkar A, Khin M, Samuel S, Ebrahim ZY, Mascha EJ, Schubert A. Ochsner J. 2011 Spring; 11(1):22-8.
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. [Contemp Clin Trials. 2011]
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT.
Kawut SM, Bagiella E, Shimbo D, Lederer DJ, Al-Naamani N, Roberts KE, Barr RG, Post W, Horn EM, Tracy R, et al. Contemp Clin Trials. 2011 Mar; 32(2):280-7. Epub 2010 Dec 10.
Bounding the Resampling Risk for Sequential Monte Carlo Implementation of Hypothesis Tests. [J Stat Plan Inference. 2010]
Bounding the Resampling Risk for Sequential Monte Carlo Implementation of Hypothesis Tests.
Kim HJ. J Stat Plan Inference. 2010 Jul; 140(7):1834-1843.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The B-value: a tool for monitoring data.
The B-value: a tool for monitoring data.
Biometrics. 1988 Jun ;44(2):579-85.

PubMed
Effect of growth rate and glucose concentration on the activity of the phosphoen...
Effect of growth rate and glucose concentration on the activity of the phosphoenolpyruvate phosphotransferase system in Streptococcus mutans Ingbritt grown in continuous culture.
Infect Immun. 1979 Feb ;23(2):224-31.

PubMed
Distribution of brain metastases.
Distribution of brain metastases.
Arch Neurol. 1988 Jul ;45(7):741-4.

PubMed
The irritable bowel syndrome and food hypersensitivity.
The irritable bowel syndrome and food hypersensitivity.
Ann Allergy. 1988 Jul ;61(1):47-9.

PubMed
Atypical ichthyosiform erythroderma and congenital neurosensory deafness--a dist...
Atypical ichthyosiform erythroderma and congenital neurosensory deafness--a distinct syndrome.
J Pediatr. 1978 Jan ;92(1):68-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: